The Inhibitory Activity of Typified Propolis against Enterococcus Species

被引：15
作者：
Moncla, Bernard J. [2 ,3 ,4 ,5 ]
Guevara, Peter W. [4 ,5 ]
Wallace, James A. [2 ,3 ]
Marcucci, Maria C. [6 ]
Nor, Jacques E. [7 ]
Bretz, Walter A. [1 ]
机构：
[1] NYU, Coll Dent, Dept Cariol & Comprehens Care, New York, NY 10010 USA
[2] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Sch Dent Med, Dept Endodont, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA
[5] Magee Womens Res Inst, Pittsburgh, PA 15260 USA
[6] Univ Anhanguera Uniban, Sch Pharm, Sao Paulo, Brazil
[7] Univ Michigan, Sch Dent, Dept Cariol Endodont & Restorat Sci, Ann Arbor, MI 48109 USA
来源：
ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES | 2012年 / 67卷 / 5-6期
关键词：
Propolis; Enterococcus; MIC; VITRO ANTIMICROBIAL ACTIVITY; ANTIBACTERIAL ACTIVITY; BRAZILIAN PROPOLIS; PHENOLIC-COMPOUNDS; IDENTIFICATION; FAECALIS; GROWTH;
D O I：
10.5560/ZNC.2012.67c0249
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Propolis, a natural bee product widely used for its antimicrobial activity, was tested against isolates of Enterococcus from humans, pig-tailed macaques, isolates of refractory endodontic treatment cases, and isolates from Lactobacillus-containing food supplements. Typification of the propolis was performed by high-performance liquid chromatography (HPLC) by which prenylated compounds, cinnamic acid derivatives, and flavonoids were detected as the main constituents. Minimum inhibitory concentrations (MIC) were determined using the agar dilution method. All human and animal Enterococcus isolates demonstrated MIC values of 1600 mu g/mL. Enterococcal species of human and animal origin were inhibited by propolis. Particularly, human isolates of E. faecium and E. faecalis of refractory endodontic treatment cases were susceptible to propolis of Brazilian origin.
引用
收藏
页码：249 / 256
页数：8
相关论文
共 35 条
  • [1] Arslan S, 2011, SAUDI MED J, V32, P479
  • [2] Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102
  • [3] Recent progress in pharmacological research of propolis
    Banskota, AH
    Tezuka, Y
    Kadota, S
    [J]. PHYTOTHERAPY RESEARCH, 2001, 15 (07) : 561 - 571
  • [4] Bretz WA, 1998, Z NATURFORSCH C, V53, P1045
  • [5] BYSTROM A, 1981, SCAND J DENT RES, V89, P321
  • [6] Vancomycin-resistant enterococci
    Cetinkaya, Y
    Falk, P
    Mayhall, CG
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (04) : 686 - +
  • [7] ANTIBACTERIAL, ANTIFUNGAL, ANTIAMOEBIC, ANTIINFLAMMATORY AND ANTIPYRETIC STUDIES ON PROPOLIS BEE PRODUCTS
    DOBROWOLSKI, JW
    VOHORA, SB
    SHARMA, K
    SHAH, SA
    NAQVI, SAH
    DANDIYA, PC
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 1991, 35 (01) : 77 - 82
  • [8] EVALUATION OF 3 DISK TESTS FOR IDENTIFICATION OF ENTEROCOCCI, LEUCONOSTOCS, AND PEDIOCOCCI
    FACKLAM, R
    PIGOTT, N
    FRANKLIN, R
    ELLIOTT, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (04) : 885 - 887
  • [9] Facklam R.R., 1999, Manual of Clinical Microbiology, V7th, P297
  • [10] Facklam R.R., 1991, Manual of clinical microbiology, V5th, P238
1234